Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

被引:0
作者
Yuru Fan
Xuan Zhang
Qin Zhang
Liang Zheng
Renpeng Zhou
Cheng Sun
Xihan Wang
Ke Song
Zhusheng He
Honghui Wang
Qian Zhang
Wei Hu
机构
[1] The Second Affiliated Hospital of Anhui Medical University,Department of Clinical Pharmacology
[2] Jiangsu Hengrui Pharmaceuticals Co.,undefined
[3] Ltd,undefined
来源
Clinical Pharmacokinetics | 2024年 / 63卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:293 / 302
页数:9
相关论文
共 91 条
  • [1] Chung KF(2022)Cough hypersensitivity and chronic cough Nat Rev Dis Primers 8 45-492
  • [2] McGarvey L(2004)The diagnosis and management of chronic cough Eur Respir J 24 481-1551
  • [3] Song WJ(2016)Chronic cough N Engl J Med 375 1544-1374
  • [4] Chang AB(2008)Prevalence, pathogenesis, and causes of chronic cough Lancet 371 1364-1481
  • [5] Lai K(2015)The global epidemiology of chronic cough in adults: a systematic review and meta-analysis Eur Respir J 45 1479-4044 e4032
  • [6] Canning BJ(2021)Impact and disease burden of chronic cough Asia Pac Allergy 11 4037-87
  • [7] Birring SS(2021)Prevalence and burden of chronic cough in the United States J Allergy Clin Immunol Pract 9 S82-27
  • [8] Smith JA(2008)Currently available cough suppressants for chronic cough Lung 186 19-923
  • [9] Mazzone SB(2005)Drugs to suppress cough Expert Opin Investig Drugs 14 909-785
  • [10] Morice AH(2022)Treatment of chronic cough: P2X3 receptor antagonists and beyond Pharmacol Ther 237 775-695